| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0004 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |